Kraig Biocraft Laboratories, Inc.
KBLB
$0.085
-$0.004-4.49%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 28.12% | 22.44% | 93.91% | 90.44% | 28.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.42% | 17.58% | 82.78% | 78.55% | 24.95% |
| Operating Income | -24.42% | -17.58% | -82.78% | -78.55% | -24.95% |
| Income Before Tax | -17.51% | -12.19% | -46.00% | -36.90% | 11.64% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -17.51% | -12.19% | -46.00% | -36.90% | 11.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -17.51% | -12.19% | -46.00% | -36.90% | 11.64% |
| EBIT | -24.42% | -17.58% | -82.78% | -78.55% | -24.95% |
| EBITDA | -24.79% | -17.83% | -83.89% | -79.50% | -25.27% |
| EPS Basic | -13.79% | -10.34% | -48.00% | -35.71% | 12.12% |
| Normalized Basic EPS | -29.41% | -16.67% | -50.00% | -33.33% | 22.73% |
| EPS Diluted | -13.79% | -10.34% | -48.00% | -35.71% | 12.12% |
| Normalized Diluted EPS | -29.41% | -16.67% | -50.00% | -33.33% | 22.73% |
| Average Basic Shares Outstanding | 0.43% | 0.51% | 0.80% | 2.08% | 3.96% |
| Average Diluted Shares Outstanding | 0.43% | 0.51% | 0.80% | 2.08% | 3.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |